هدف اصلی از داروهای عمومی از دیدگاه سرمایه گذاری: مورد کلوپیدوگرل

The case of clopidogrel indicates that the entrance of generics may increase patient access to effective medicines, most notably in lower-income countries, thereby reducing inequalities between European patients. Policymakers should also consider this investment aspect of generic medicines when designing pharmaceutical policies.